Show simple item record

dc.contributor.authorMohammadi, G
dc.contributor.authorNokhodchi, A
dc.contributor.authorBarzegar-Jalali, M
dc.contributor.authorLotfipour, F
dc.contributor.authorAdibkia, K
dc.contributor.authorEhyaei, N
dc.contributor.authorValizadeh, H
dc.date.accessioned2018-08-26T08:06:44Z
dc.date.available2018-08-26T08:06:44Z
dc.date.issued2011
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/50077
dc.description.abstractThe objective of the present study was to prepare clarithromycin (CLR) loaded biodegradable nanoparticles (NPS), with a view to investigate its physicochemical properties and anti-bacterial activity. PLGA was used as a biodegradable polymer and the particles were prepared by nano-precipitation method in 3 different drugs to polymer ratios. Evaluation of the physicochemical properties of the prepared nanoparticles was performed using encapsulation efficiency, nanoparticle production yield, dissolution studies, particle size analysis, zeta potential determination, differential scanning calorimetry, Fourier-transform infrared spectroscopy and X-ray powder diffractometry. The antimicrobial activity against Staphylococcus aureus was determined using serial dilution technique to achieve the minimum inhibitory concentration (MIC) of NPs. The particles were between 189 and 280 nm in size with narrow size distribution, spherical shape and 57.4-80.2% entrapment efficiency. Zeta potential of the NPs was fairly negative. The DSC thermograms and X-ray diffraction patterns revealed reduced drug crystallinity in the NPs. FT-IR spectroscopy demonstrated possible noncovalent interactions between the drug and polymer. In vitro release study showed an initial burst followed by a plateau during a period of 24 h. The NPs were more effective than intact CLR against S. aureus so that the former showed equal antibacterial effect at 1/8 concentration of the intact drug. In conclusion, the prepared CLR nanoparticles are more potent against S. aureus with improved MICs and appropriate physicochemical properties that may be useful for other susceptible microorganisms and could be an appropriate candidate for intravenous, ocular and oral and topical preparations. (C) 2011 Elsevier B.V. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofCOLLOIDS AND SURFACES B-BIOINTERFACES
dc.subjectNanoparticle
dc.subjectClarithromycin
dc.subjectPLGA
dc.subjectMIC
dc.subjectS. aureus
dc.titlePhysicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system
dc.typeArticle
dc.citation.volume88
dc.citation.issue1
dc.citation.spage39
dc.citation.epage44
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.colsurfb.2011.05.050


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record